Manufacturers of Alzheimer’s disease drugs have identified blood tests as a way to accelerate diagnosis and treatment.

Labcorp is now offering a blood-based biomarker test in the U.S. to support the diagnosis ... assays and PET imaging cleared by the Food and Drug Administration. The sensitivity and specificity ...

Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today the nationwide launch of its pTau-217/Beta Amyloid 42 Ratio, a powerful new blood-based ...

The most recent lawsuit is from winter 2024, when the California attorney general announced a $5 million settlement with ...

With over 600 million tests performed annually and involvement in 90% of FDA-approved drugs in 2023, Labcorp (NYSE:LH) provides laboratory testing services and drug development solutions to ...

Detailed price information for Quest Diagnostics Inc (DGX-N) from The Globe and Mail including charting and trades.

Labcorp Holdings Inc. LH, or Labcorp’s strong focus on key specialty testing areas, such as oncology, women’s health, autoimmune disease and neurology, is poised to help it grow in the upcoming ...

Labcorp will phone or email if results require ... about their symptoms before getting a vitamin deficiency test. The Food and Drug Administration (FDA) states that at-home tests can effectively ...

The company also strikes deals with pharmaceutical companies that use de-identified genetic data to aid their drug discovery work ... lower sales volume for its test kits. When 23andMe went ...

The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how testing & diagnostics services stocks fared in Q4, starting ...